January 06, 2025 04:31 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
Bharat Biotech-Covaxin
Image tweeted by @IndianEmbassyTR

Covaxin supplied to 18 states directly since May 1: Bharat Biotech

| @indiablooms | May 12, 2021, at 05:24 am
#BharatBiotech #Covaxin #COVID19 #IndiaFightsCorona

New Delhi/IBNS: Vaccine maker Bharat Biotech on Tuesday informed that it has directly supplied Covaxin to 18 states since May 1.

The pharmaceutical brand also urged people to get vaccinated assuring that it will continue a steady supply of vaccines to the states.

"COVAXIN® has been directly supplied to 18 states since May 1st. Unflinching in our efforts, we will continue the steady supply of our #vaccine. Get yourself and your loved ones vaccinated," the company said in a statement.

The company is supplying its vaccine directly to Andhra Pradesh, Assam, Bihar, Chhattisgarh, Delhi, Gujarat, Haryana, Jammu and Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Tripura, Telangana, Uttar Pradesh, and West Bengal.

Bharat Biotech's indigenous vaccine-Covaxin-has been developed in collaboration with the Indian Council for Medical Research (ICMR).

It was approved for emergency use by the  Drugs Controller General of India (DCGI) in January.

Covaxin has been declared to be an 81 per cent success during the Phase 3 clinical trials in India. 

On April 29, Bharat Biotech reduced the price of Covaxin from Rs 600 per dose to Rs 400 for the state governments in view of the challenges faced by the already overstretched health system, the company had said.

The vaccination programme in India which started on Jan 16, was last month widely expanded to include citizens above 18 years of age as a part of the Centre's Liberalised Pricing & Accelerated National COVID-19 Vaccination strategy.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Images
Cyclone Dana: Heavy rains lash Kolkata, widespread waterlogging reported from several areas
Cyclone Dana: Heavy rains lash Kolkata, widespread waterlogging reported from several areas Oct 25, 2024, at 11:15 pm
Farmers working at dragon fruit garden in Agaratala
Farmers working at dragon fruit garden in Agaratala Jun 30, 2021, at 05:07 am
Swami Ramdev, Achariya Balakrishna perform Yoga with followers at Haridwar
Swami Ramdev, Achariya Balakrishna perform Yoga with followers at Haridwar Jun 22, 2021, at 01:59 am